IU scientists reveal distinct sleep states, opening new path in sleep genetics
A new study from IU shows fruit flies have different sleep states with unique regulation, reshaping how scientists investigate sleep mechanisms and the genetic basis of rest.
Richard DiMarchi, pioneering IU peptide chemist behind many GLP-1 drugs, re-shapes obesity treatment
IU’s transformative researchers contributed to some of the nation’s most significant and life-altering innovations in chemistry, including Crest toothpaste and GLP-1 drugs to treat obesity.
IU engineers cellular brain models to push new boundaries in Alzheimer’s research
Gill Institute affiliate Feng Guo's AI-powered organoid technologies are opening new pathways to understand brain function and accelerate discoveries in Alzheimer’s research.
Professor Richard DiMarchi and Professor Matthias Tschöp receives the Rolf Luft Award 2026
Professors Richard Dennis DiMarchi, Indiana University, Bloomington, USA and Matthias Tschöp, Ludwig Maximillian University, Munich, Germany are awarded the Rolf Luft Award 2026 for outstanding, groundbreaking scientific contribution in diabetes and obesity with basic research leading to important clinical implications.
Discoveries from Dr. Richard DiMarchi’s lab at Indiana University are now powering three clinical trials with MBX Biosciences.
Indiana University scientists have discovered that a brain enzyme involved in cannabis-like signaling plays an unexpected role in anxiety and social behavior, reshaping our understanding of the cerebellum beyond movement control.
Dr. Hohmann receives the Raphael Mechoulam Award
Congratulations to Dr. Hohmann on receiving the Raphael Mechoulam Award at the 2025 ICRS Conference. Her lab members, Gabriel Henrique Dias de Abreu and Jonah Wirt also won the pre-doctoral trainee award!
Gill Chair Driving Discoveries
IU Distinguished Professor Richard DiMarchi joins President Pamela Whitten to talk about his pioneering research that's transforming the treatment of obesity worldwide.
A new study by Gill researchers at IU Bloomington investigates why velvet ant stings are among the most excruciating in the animal kingdom.
Gill Chair's Startup Announces IPO
MBX Biosciences, Inc., a startup co-founded by Gill Chair Richard DiMarchi, recently raised $163.2 million in its U.S. initial public offering. The company aims to help individuals with endocrine and metabolic diseases such as chronic hypoparathyroidism live healthier lives.
Dr. Shafer, Professor and newly appointed Gill Chair, joins IU to expand his research into what makes our internal clocks tick.
IU Vice President for Research Russell Mumper outlines recent changes that will better support researchers and meet our ambitious goals for the year.
Dr. DiMarchi to be honored for breakthrough research in obesity drug discovery.
